OISB research team lead by Alain Stintzi has received $1,971,800 from CIHR to study the chronic effects of inflammatory bowel disease.
Learn more about the innovative work of Drs Stintz, Figeys and Mack on the role the gut microbiome plays in Crohn's disease and ulcerative colitis: